Stifel Financial
SGMO

Stifel Financial’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Stifel Financial’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-26,295
Closed -$239K – 2363
2015
Q4 		$239K Buy
+26,295
New +$203K ﹤0.01% 2029
2015
Q3 		– Sell
-107,868
Closed -$1.2M – 2351
2015
Q2 		$1.2M Sell
107,868
-289,875
-73% -$3.74M 0.01% 1275
2015
Q1 		$6.23M Buy
+397,743
New +$6.15M 0.03% 538

Other funds holding SGMO

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Stifel Financial's SGMO Position: Q1 2016 in Review

Stifel Financial sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q1 2016, closing a stake of 26,295 shares — an estimated $239K sold.

Stifel Financial first reported a position in SGMO in Q1 2015 and held it in 3 quarters. The position peaked at $6.23M in Q1 2015. 143 funds tracked by Wall St. Rank hold SGMO as of Q1 2016.

  • Stifel Financial reported no remaining SANGAMO THERAPEUTICS INC position as of Q1 2016 after selling out during the quarter.
  • Stifel Financial sold 26,295 SANGAMO THERAPEUTICS INC shares in Q1 2016, an estimated $239K.
  • Stifel Financial first reported a position in SANGAMO THERAPEUTICS INC in Q1 2015 and held it in 3 quarters.
  • Stifel Financial's SANGAMO THERAPEUTICS INC position peaked at $6.23M in Q1 2015.
  • 143 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q1 2016.

Based on Stifel Financial's 13F filing for Q1 2016, filed 16 May 2016.